AN

Ananda Pharma Plc

Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BDQPXQ60
LEI:
894500DFM8VOC5FW4X47
Country:
United Kingdom
Address:
6th Floor, 60 Gracechurch Street, EC3V 0HR London
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ananda Pharma Plc is a biopharmaceutical company focused on the development and commercialization of regulatory-approved, cannabinoid-based medicines. The company's pipeline targets complex, chronic conditions with significant unmet medical needs. Key therapeutic areas of focus include inflammatory pain conditions, such as Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, alongside drug-resistant epilepsies and Heart Failure with preserved Ejection Fraction (HFpEF). Ananda's integrated approach spans from initial research and drug candidate optimization through to conducting clinical trials and securing marketing authorizations from regulators to ensure patient access.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Ananda Pharma Plc. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 15:43
Post-Annual General Meeting Information
Result of Annual General Meeting
English 29.6 KB
2025-08-19 08:00
Report Publication Announcement
Webinar Presentation Release
English 21.3 KB
2025-07-30 14:49
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 21.8 KB
2025-07-30 13:44
Report Publication Announcement
Publication of Annual Report
English 44.2 KB
2025-06-23 08:00
Regulatory News Service
Key Milestone in MRX1 Path to Clinical Trials
English 23.3 KB

Automate Your Workflow. Get a real-time feed of all Ananda Pharma Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ananda Pharma Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK